Skip to main content
Caplight Logo









Surrozen

Surrozen

Public
South San Francisco, CaliforniaHealthcarehttps://www.surrozen.com

Surrozen is now publicly traded

The data on this page reflects Surrozen's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Mar 24, 2025

Total Funding Raised

$445.5M

Company Overview

Surrozen (NAS: SRZN) is a biotechnology company focused on discovering and developing drug candidates that selectively modulate the Wnt pathway to promote tissue repair across various organs and tissues.

Sector

Healthcare

AI Layer

Non-AI

Keywords

wnt pathway modulation therapeuticstissue-specific wnt pathway activationantibody-based regenerative medicineproprietary antibody engineering platformsophthalmology drug developmenttherapeutics for severe retinal diseasesbiologic drug discovery and licensingfzd4-targeted antibody developmentbispecific and trispecific antibody therapeuticswet AMD and diabetic retinopathy therapeuticsclinical-stage biotechnology company

Surrozen Comparables

Compare Surrozen with similar companies based on industry and business-model similarity.

Surrozen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuvasq Biotechnologies
77%
RevOpsis Therapeutics
75%
Radiant Biotherapeutics
57%

Surrozen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementMar 24, 2025
Private PlacementApr 1, 2024
PIPEAug 11, 2021
Series CJun 19, 2020
Series BMar 14, 2019
Series A
Feb 15, 2017

Surrozen Investors

Notable investors and investment history

Surrozen investors
InvestorRounds
The Column GroupPIPE, Series C, Private Placement, Series B, Series A
Horizons VenturesSeries B, Series C
RA Capital ManagementPrivate Placement
BraidwellPrivate Placement
5AM VenturesPrivate Placement
The Chernin GroupPrivate Placement, Series C, Series A, Series B
Acuta Capital PartnersPrivate Placement

Surrozen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Surrozen Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range66
Year Founded2016
Last FundingMar 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?